Oliver Ebert

2.1k total citations
50 papers, 1.5k citations indexed

About

Oliver Ebert is a scholar working on Genetics, Animal Science and Zoology and Molecular Biology. According to data from OpenAlex, Oliver Ebert has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Genetics, 23 papers in Animal Science and Zoology and 14 papers in Molecular Biology. Recurrent topics in Oliver Ebert's work include Virus-based gene therapy research (34 papers), Animal Virus Infections Studies (23 papers) and CAR-T cell therapy research (10 papers). Oliver Ebert is often cited by papers focused on Virus-based gene therapy research (34 papers), Animal Virus Infections Studies (23 papers) and CAR-T cell therapy research (10 papers). Oliver Ebert collaborates with scholars based in Germany, United States and Japan. Oliver Ebert's co-authors include Savio L.C. Woo, Katsunori Shinozaki, Jennifer Altomonte, Adolfo Garcı́a-Sastre, Roland M. Schmid, Sabrina Marozin, Tiangui Huang, Chryssanthi Kournioti, Marcia Meseck and Lan Wu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Oliver Ebert

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Ebert Germany 24 1.0k 549 440 424 406 50 1.5k
Katherine L. Molnar-Kimber United States 27 1.1k 1.1× 577 1.1× 131 0.3× 886 2.1× 336 0.8× 37 2.1k
Zong-Yi Li United States 20 1.4k 1.4× 746 1.4× 87 0.2× 1.1k 2.6× 281 0.7× 23 1.9k
Carolina S. Ilkow Canada 17 660 0.6× 585 1.1× 114 0.3× 509 1.2× 298 0.7× 41 1.2k
Phonphimon Wongthida United States 21 1.2k 1.2× 866 1.6× 282 0.6× 710 1.7× 507 1.2× 31 1.8k
Christine E. Engeland Germany 18 792 0.8× 674 1.2× 168 0.4× 385 0.9× 257 0.6× 38 1.1k
Dominic G. Roy Canada 18 708 0.7× 644 1.2× 101 0.2× 466 1.1× 391 1.0× 31 1.2k
Shaoheng Ni United States 23 1.7k 1.6× 905 1.6× 102 0.2× 1.3k 3.1× 287 0.7× 27 2.1k
Matthew Coffey United States 22 1.6k 1.6× 848 1.5× 247 0.6× 842 2.0× 275 0.7× 45 2.1k
Lihua Tao United States 21 534 0.5× 627 1.1× 74 0.2× 541 1.3× 281 0.7× 51 1.3k
Moanaro Biswas United States 23 550 0.5× 351 0.6× 79 0.2× 539 1.3× 300 0.7× 52 1.3k

Countries citing papers authored by Oliver Ebert

Since Specialization
Citations

This map shows the geographic impact of Oliver Ebert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Ebert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Ebert more than expected).

Fields of papers citing papers by Oliver Ebert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Ebert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Ebert. The network helps show where Oliver Ebert may publish in the future.

Co-authorship network of co-authors of Oliver Ebert

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Ebert. A scholar is included among the top collaborators of Oliver Ebert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Ebert. Oliver Ebert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mall, Sabine, Katja Steiger, Roland M. Schmid, et al.. (2018). Enhanced Safety and Efficacy of Oncolytic VSV Therapy by Combination with T Cell Receptor Transgenic T Cells as Carriers. Molecular Therapy — Oncolytics. 12. 26–40. 30 indexed citations
2.
Phillip, Veit, Sebastian Rasch, Oliver Ebert, et al.. (2016). Influence of Sorafenib and Bevacizumab on pancreatic volume – A monocentric CT based analysis. Pancreatology. 16(4). 621–624. 8 indexed citations
3.
Groß, Claudia, Katja Steiger, Irina Heid, et al.. (2015). Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib. Clinical Cancer Research. 21(19). 4440–4450. 24 indexed citations
4.
Marozin, Sabrina, Jennifer Altomonte, Enrico N. De Toni, et al.. (2015). STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma. Cancer Gene Therapy. 22(6). 317–325. 10 indexed citations
5.
Martín, Claudia Sánchez-San, Achim Aigner, Stephan Singer, et al.. (2013). Depletion of the transcriptional coactivators megakaryoblastic leukaemia 1 and 2 abolishes hepatocellular carcinoma xenograft growth by inducing oncogene‐induced senescence. EMBO Molecular Medicine. 5(9). 1367–1382. 40 indexed citations
6.
Shinozaki, Katsunori, Takemasa Sakaguchi, Marcia Meseck, et al.. (2012). The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer. International Journal of Molecular Medicine. 31(2). 299–306. 19 indexed citations
7.
Altomonte, Jennifer & Oliver Ebert. (2011). Replicating viral vectors for cancer therapy: strategies to synergize with host immune responses. Microbial Biotechnology. 5(2). 251–259. 12 indexed citations
8.
Braren, Rickmer, Jennifer Altomonte, Marcus Settles, et al.. (2011). Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization. Journal of Hepatology. 55(5). 1034–1040. 32 indexed citations
9.
Esposito, Iréne, et al.. (2011). Preoperative radiological characterization of hepatic angiomyolipoma using magnetic resonance imaging and contrast-enhanced ultrasonography: a case report. Journal of Medical Case Reports. 5(1). 481–481. 7 indexed citations
10.
Braren, Rickmer, Jelena Curcic, Jennifer Altomonte, et al.. (2011). Free-Breathing Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging in a Rat Liver Tumor Model Using Dynamic Radial T1 Mapping. Investigative Radiology. 46(10). 624–631. 17 indexed citations
11.
Marozin, Sabrina, Enrico N. De Toni, Jennifer Altomonte, et al.. (2010). Cell Cycle Progression or Translation Control Is Not Essential for Vesicular Stomatitis Virus Oncolysis of Hepatocellular Carcinoma. PLoS ONE. 5(6). e10988–e10988. 9 indexed citations
12.
Ebert, Oliver. (2009). Onkolytische Virotherapie mit Vesikulären Stomatitisviren. DMW - Deutsche Medizinische Wochenschrift. 134(44). 2236–2238. 1 indexed citations
13.
Altomonte, Jennifer, Sabrina Marozin, Roland M. Schmid, & Oliver Ebert. (2009). Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular Carcinoma. Molecular Therapy. 18(2). 275–284. 73 indexed citations
14.
Altomonte, Jennifer, Rickmer Braren, Stephan Schulz, et al.. (2008). Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats. Hepatology. 48(6). 1864–1873. 39 indexed citations
15.
Marozin, Sabrina, Jennifer Altomonte, Florian J. Stadler, et al.. (2008). Inhibition of the IFN-β Response in Hepatocellular Carcinoma by Alternative Spliced Isoform of IFN Regulatory Factor-3. Molecular Therapy. 16(11). 1789–1797. 42 indexed citations
16.
Shin, Edward J., Georges Wanna, Bryan D. Choi, et al.. (2007). Interleukin‐12 Expression Enhances Vesicular Stomatitis Virus Oncolytic Therapy in Murine Squamous Cell Carcinoma. The Laryngoscope. 117(2). 210–214. 62 indexed citations
17.
Altomonte, Jennifer, Lan Wu, Li Chen, et al.. (2007). Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo. Molecular Therapy. 16(1). 146–153. 65 indexed citations
18.
Ebert, Oliver, Sonal Harbaran, Katsunori Shinozaki, & Savio L.C. Woo. (2004). Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice. Cancer Gene Therapy. 12(4). 350–358. 79 indexed citations
19.
Lilienfeld‐Toal, Marie von, Oliver Ebert, I. Theuerkauf, Axel Glasmacher, & Ingo G.H. Schmidt‐Wolf. (2001). Small bowel obstruction in acute myelogenous leukemia: stenosis or paralysis?. Annals of Hematology. 80(10). 611–613. 6 indexed citations
20.
Lefterova, Petja, et al.. (2000). MODULATION OF CELL SURFACE MARKERS ON NK-LIKE T LYMPHOCYTES BY USING IL-2, IL-7 OR IL-12 IN VITRO STIMULATION. Cytokine. 12(9). 1385–1390. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine L. Molnar-Kimber Breakdown of academic impact, for papers by Zong-Yi Li Breakdown of academic impact, for papers by Carolina S. Ilkow Breakdown of academic impact, for papers by Phonphimon Wongthida Breakdown of academic impact, for papers by Christine E. Engeland Breakdown of academic impact, for papers by Dominic G. Roy Breakdown of academic impact, for papers by Shaoheng Ni Breakdown of academic impact, for papers by Matthew Coffey Breakdown of academic impact, for papers by Lihua Tao Breakdown of academic impact, for papers by Moanaro Biswas
Rankless by CCL
2026